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Background: Surra, a vector borne disease caused by Trypanosoma (T.) evansi, affects the health, productivity and
working capacity of camels. Since clinical signs are not pathognomonic, diagnosis must be confirmed by laboratory
methods. This is a first study on the prevalence of surra in Cholistan Desert, Pakistan using a broad variety of
diagnostic tests thereby emphasizing it as a risk for the dromedaries of Pakistan.
Methods: In a cross sectional study, 1005 dromedary camels from three districts in the Cholistan Desert were
sampled to assess the prevalence of trypanosomosis due to T. evansi by means of parasitological (Giemsa stained
thin smear), serological (formol gel test, CATT/T. evansi, ELISA/VSG RoTat 1.2, immune trypanolysis) and molecular
tests (TBR1/2 PCR and RoTat 1.2 PCR). Kappa was calculated to assess the degree of agreement between different
tests whereas chi-square test along with odds ratios and their 95 % confidence intervals were used to study
influence of breed, gender, age and locality on disease prevalence.
Results: Overall prevalence was 0.7 % with Giemsa stained thin smears (GST), 40.1 % with formol gel test (FGT), 47.7 %
with CATT/T. evansi, 44.2 % with ELISA/VSG RoTat 1.2, 39.9 % with immune trypanolysis (TL), 31.9 % with TBR1/2 PCR
and 30.5 % with RoTat1.2 PCR. Based on these results, the Cholistan Desert appears to be a high risk area for surra.
According to TL and TBR1/2 PCR, camels at Bahawalpur are approximately two times more likely to be infected than
those in Bahawalnagar (OR = 1.8; 95 % CI: 1.38-2.42) and Rahim Yar Khan (OR = 1.9; 95 % CI: 1.30-2.75). Test agreement
of TL was moderate with CATT/T. evansi (k = 0.43; 95 % CI: 0.378-0.489) and ELISA/VSG RoTat 1.2 (k = 0.54; 95 % CI:
0.489-0.594) and poor with the other tests. Test agreement between TBR1/2 PCR and RoTat1.2 PCR was almost perfect
(k = 0.96; 95 % CI: 0.950-0.984). We didn't find evidence for the presence of T. evansi type B in the studied population.
Conclusion: Our study supports using antibody detection tests, rather than parasitological and molecular examination,
to assess surra prevalence in camels. It also calls for implementation of measures to control surra in the Cholistan
Desert.
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Trypanosoma evansi (T. evansi) was first isolated in
1880 from infected camels and equids in the Dera Ismail
Khan district of the Punjab, in what today is Pakistan. It
is a protozoan parasite of both intra- and extra vascular
fluids of mammals causing the disease surra throughout
tropical and subtropical areas of the world, including
Asia, Africa and Latin America [1, 2]. It has a large diver-
sity of mammalian hosts and has the ability to periodically
switch its major variant surface glycoprotein (VSG), pro-
ducing relapses of parasitaemia. These highly immuno-
genic VSGs determine the variable antigen type (VAT) of
an individual trypanosome and induce the production of
VAT specific protective antibodies with opsonising, agglu-
tinating and lytic activity [3, 4]. The predominant VAT
RoTat 1.2 is shown to be expressed in all T. evansi Type A
isolates other than non RoTat 1.2 T. evansi type A and T.
evansi type B that lack both RoTat 1.2 genes and their as-
sociated VSGs. Mostly,T. evansi isolates around the world
are found to be genetically homogenous [5]. T. evansi is
not cyclically transmitted; it is mechanically transmitted
by hematophagous flies (Tabanus, Atylotus, Chrysops,
Haematopota, Lyperosia and Stomoxys) and also biologic-
ally by vampire bats (Desmondus rotundus) in South
America [6].
Camel trypanosomosis is a serious problem in camel
husbandry and is a major threat to productivity and eco-
nomic losses. Camels are also affected to a lesser extent
by tsetse-transmitted trypanosome species like T. simiae,
T. brucei, T. congolense and T. vivax [7]. The course of
infection ranges from an acute form with high mortality
to a chronic form, which is characterised by reduced fer-
tility, generalised loss of body condition, neuropathy and
immune suppression coupled with anaemia and eventu-
ally death in both domestic and wild mammals [8].
Absence of pathognomonic signs of the disease necessi-
tates laboratory diagnosis to be carried out for confirm-
ation of infection. Some routinely employed parasitological
tests in ascending order of sensitivity are microscopic
examination of fresh or stained blood smears, microhae-
matocrit centrifugation technique (MHCT), miniature
anion-exchange centrifugation technique (mAECT) and
rodent inoculation. Antigen based tests might comple-
ment parasitological tests to detect active infection, but
they suffer from low sensitivity owing to fluctuating para-
sitaemia, low parasite numbers in chronic infections and
presence of antigen-antibody complexes. Various studies
have used an antigen-detecting latex agglutination test
(Suratex) and an antigen ELISA to asses prevalence of
surra in camels [9–13].
As an alternative to parasitological tests, serological
immunoassays can be applied for diagnosis of surra.
Non-specific antibody tests like the formol gel, the mer-
curic chloride and the thymol turbidity test are routinelyused for screening surra in poor-resource laboratories.
More sophisticated antibody detection tests such as the
card agglutination test (CATT/T. evansi) [14], the im-
mune trypanolysis (TL) assay [3], the latex agglutination
test [15], the immunofluorescence antibody test (IFAT)
[16] and the enzyme-linked immunosorbent assay for T.
evansi have been employed in different studies on camel
trypanosomosis [17–21]. Although sensitive and accur-
ate, these tests cannot differentiate between past and re-
cent infections.
Polymerase chain reaction (PCR) is considered to be su-
perior to parasite detection and antigen detection tests
due to its sensitivity in detecting the prepatent and
chronic phase of an infection. PCR is reported to be able
to detect 1 trypanosome/ml of blood or as low as 1 pg of
Trypanosoma DNA in the presence of host DNA [22, 23].
For molecular analysis, various target sequences such as
kinetoplast DNA, ribosomal DNA, internal transcribed
spacer region and VSG genes are reliable targets for the
detection of T. evansi [24].
After the outbreak of surra in camels during 1985–1986
in Baluchistan, several studies on the prevalence of surra
in camels have been conducted in different areas of
Pakistan [1, 25–28]. According to the Food and Agricul-
ture Organization Statistics (FAOSTATS), Pakistan is sup-
porting approximately 1.0 million head of dromedary
camels [29]. The impact of the disease on camels in
Pakistan and subsequent economic loss is currently diffi-
cult to assess because of lack of diagnostic tools for judg-
ing the extent of its incidence, prevalence and morbidity
in the field. The aim of the study was to assess the preva-
lence of camel trypanosomosis in the Cholistan Desert
and to compare the diagnostic effectiveness of several
parasitological, serological and molecular diagnostics.
Methods
Study site
The hot and hyper arid sandy Cholistan Desert is an ex-
tension of the Great Indian Desert and stretches over an
area of 26,330 Km2 (Fig. 1). It lies in the Southern Pun-
jab of Pakistan between latitudes of 27° 42’ and 29°45’N
and longitudes of 69° 52’ to 75° 24’E and comprises three
districts, Rahim Yar Khan, Bahawalpur and Bahawalna-
gar. The Cholistan Desert is classified as a “tropical des-
ert” with annual mean temperatures lying between 20 °C
and 40 °C. The mean annual rainfall varies from less
than 100 mm in the west to 200 mm in the east. Ab-
sence of permanent water bodies is compensated by col-
lection of rainwater in artificial ponds known as “tobas”
in local dialect. Drying up of tobas causes migration of
nomads and animals to semi-permanent settlements
where primitive unlined wells and kunds (usually lined)
are available and drying up of the latter causes
Fig. 1 Map of Pakistan with the Cholistan Desert and the three districts. Localisation of sampling sites is shown in red dots
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water and fodder are available [30].
The total livestock population of the Cholistan Desert
is estimated to be 1.56 million with camels (0.08 million
head), cattle (0.67 million), sheep (0.45 million) and
goats (0.35 million) as the predominant types of live-
stock. Insufficient water, nutrition, non-domesticated
production system, marketing, animal health and pro-
duction services are some of the constraints for livestock
productions [31].The vegetation coverage is poor. Calligonum polygo-
noides, Acacia jacquemontii, Haloxylon recurvum, Haloxy-
lon salicornicum, Salsola baryosma, Suaeda fruticosa,
Capparis decidua, Prosopis cineraria, Panicum turgidum,
Sporobolus iocladus, Aeluropus lagopoides, Crotalaria
burhia, Aerva persica, Calotropis procera, Pulicaria rajpu-
tanae serve as a common source of fodder for camels
[32]. Hematophagous flies such as Tabanus spp, Hemato-
bia spp. and Stomoxys spp are abundant (unpublished
data).
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The study population consisted of dromedary camels of
all age groups residing in Cholistan and managed under
pastoral production systems. Within the three districts of
Cholistan Desert, specific study sites were chosen purpos-
ively where camels congregated for watering and browsing
purposes. Every fifth animal (n = 1005) was selected from
the population at different grazing and watering points on
a monthly basis from January 2012 to December 2013.
The age of the animals recorded was based on information
from the owners. Camels below 2 years of age were con-
sidered as calves, those between 2 to 4 years as young ani-
mals, while those above 4 years of age were considered as
adults. Each animal was examined clinically and informa-
tion on different aspects like age, gender, breed, month of
sampling, previous trypanocide treatment, history of abor-
tions and weight estimations were also recorded [33].
Blood sampling
Ten ml of blood were collected from the jugular vein.
Four ml of blood were placed into a tube containing
EDTA for packed cell volume (PCV) measurement and
for DNA extraction and was stored in cool boxes until
transported to the laboratory. It was later aliquoted into
labelled microtubes and preserved at −80 °C till further
analysis. For serological tests, 3 ml of blood were placed
in serum separator tubes with clot activators. After cen-
trifugation for 15 min at 2000 rpm, serum was aliquoted
and stored at −80 °C. Serum volumes of 200 μl were
later spotted onto Whatman filter paper No. 4 for fur-
ther analysis.
Ethical approval
The study protocol was conducted with the ethical ap-
proval of Advance Studies And Research Board (ASRB) of
the Government College University, Pakistan. The proto-
col for the culture of trypanosomes in mice was approved
by the Veterinary Ethical Committee of the Institute of
Tropical Medicine Antwerp, Belgium (ITM) (BM2013-7).
Parasitological examination
A small drop of blood (3–5 μl) was placed at one end of a
clean microscope slide and a thin film was drawn out. It
was air-dried and fixed in methyl alcohol for 1 min and
allowed to dry. The smears were stained with Giemsa (one
drop of Giemsa + 1 ml PBS, pH 7.2) for 25 min, followed
by washing of the slides in tap water and drying. The
Giemsa stained thin smears (GST) were examined at a
magnification of 400–1000x with oil immersion [34].
Determination of packed cell volume (PCV)
Approximately 70 μl of blood were put into a hepari-
nised capillary tube (75 × 1.5 mm). The dry end was
closed with plasticine and centrifuged at 14000 rpm for5 min. The PCV was expressed as percentage of the total
blood volume [34].
Serological analysis
The formol gel test (FGT) was carried out by adding
two drops of concentrated formalin solution (37 %
formaldehyde) to 1 ml of serum. The test was consid-
ered positive if the serum coagulated immediately and
turned white [34].
Immune trypanolysis (TL) was carried out according to
the protocol of Holland et al. [35] with T. evansi VAT
RoTat 1.2. One confetti of 6 mm diameter was punched
out from each filter paper having sera blotted onto it and
later transferred to a flat bottom polystyrene microtitre
plate (Greiner Bio-One, Wemmel, Belgium). Twenty μl of
guinea pig serum were poured onto each filter paper and
allowed to be absorbed for 5 min. A suspension of 5–10
trypanosomes per microscopic field (40 x magnifications)
was made in guinea pig serum and 10 μl of this trypano-
some suspension were added to each sample well and the
plate was shaken for 90 min. One drop of the trypano-
some suspension was examined under the microscope
and the percentage of lysed trypanosomes was recorded. If
50 % or more of the trypanosomes were lysed, the test was
considered positive.
ELISA/VSG RoTat 1.2 was carried out as described by
Verloo et al. [18]. For coating ELISA plates, the purified
antigen (VSG RoTat 1.2) was diluted to a concentration of
2 μg/ml in PBS buffer (0.01 M; pH 7.4; NaCl 8.2 g/l; NaH2-
PO4.H2O 0.2 g/l; Na2HPO4.2H2O 1.44 g/l). One hundred
fifty μl of the diluted antigen were added per well and
stored at −4 °C overnight. Half of the wells were left empty
as antigen negative control. The antigen was removed and
350 μl of PBS-Blotto (0.01 M; pH 7.4; NaCl 11.7 g/l; NaH2-
PO4.H2O 0.2 g/l; Na2HPO4.2H2O 1.44 g/l; NaN3 0.5 g/l;
skimmed milk powder 10 g/l) were added per well for
blocking the plate. The plate was then incubated for one
hour at room temperature followed by three times washing
with a 1 min interval using 350 μl of PBS-Tween (PBS with
Tween 20 0.5 ml/l) per well. Sera collected on filter paper
were eluted by punching out one confetti of 6 mm diam-
eter from each sample and adding 1.0 ml of PBS Blotto-
Tween for overnight incubation at 4 °C. A volume of
150 μl of the eluted fraction was added in duplicate to an
antigen coated and an antigen free well in an ELISA plate
and incubated at room temperature for an hour. Washing
was done three times with 350 μl of PBS-Tween prior to
addition of 150 μl/well of protein A peroxidase conjugate
(1/10,000 dilution in PBS-Tween). Plates were incubated
for one hour at room temperature followed by five times
washing with 350 μl of PBS-Tween where after 150 μl of
substrate-chromogen solution were added per well and in-
cubated for 60 min at room temperature. Absorption was
read at 414 nm in a Labsystems Multiskan RC ELISA
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and of the serum controls was calculated by subtracting
the mean O.D. of the two antigen negative wells from the
mean O.D. of the two corresponding antigen containing
wells. These corrected O.D.s were expressed as percentage
of the O.D. obtained with the strong positive control in-
cluded in each plate (percent positivity, P.P.). If for a given
sample the difference between the two raw O.D.s was more
than 25 % of their mean, the results were rejected and the
sample retested. Cut-off value for ELISA–confetti was cal-
culated to be 14 %.
Sera were also tested for the presence of anti-T. evansi
antibodies using the card agglutination test for T. evansi
(CATT/T. evansi) (Institute of Tropical Medicine,
Antwerp, Belgium). Approximately, 45 μl of the antigen
were transferred onto the test card and mixed with 25 μl
of the test sera diluted at 1/4 with PBS pH 7.2 as per
manufacturer’s instructions. The card was agitated for
5 min and the reaction was checked in the clear light.
Positive reaction was confirmed on recording agglutina-
tions (blue agglutinates) [14].
Molecular analysis
Three molecular tests were performed which are able to
detect genomic DNA of T. evansi and therefore are not
affected by the existence of dyskinetoplast T. evansi
strains [36, 37]. The TBR1/2 PCR amplifies mini-
chromosome satellite repetitive sequences and is consid-
ered the gold standard for detection of Trypanozoon
DNA and allows as little as 1–5 trypanosomes/ml of
blood to be detected [34, 38]. The RoTat 1.2 PCR is spe-
cific for T. evansi type A and is capable to detect as few
as 50 trypanosomes/ml of blood [39]. T. evansi type B
PCR targets minicircle sequences [39].
Genomic DNA was extracted from 250 μl of whole
camel blood using a commercially available kit (Pure
link, Genomic DNA minikit, Invitrogen) and was stored
at −80 °C till further use.
One pair of Trypanozoon-specific and two pairs of
species-specific primers were employed for analysis
(Table 1).
TBR1/2 PCR was carried out in a 25 μl reaction mixture
containing 2x gold Taq Master Mix (Invitrogen), 0.8 μM
forward and reverse primers and 2.5 μl of template DNA.Table 1 Details on the primers used in the molecular tests
Name Specificity Target
TBR1/2 Trypanozoon Minichromosome sat
repetitive sequence
RoTat 1.2 Trypanosoma evansi type A RoTat 1.2 VSG
Eva B Trypanosoma evansi type B Minicircle genesThe cycles included activation at 95 °C for 5 min, followed
by 30 cycles of denaturing at 95 °C for 30 s, annealing at
55 °C for 30 s and extension at 72 °C for 30 s. Final elong-
ation was continued at 72 °C for 5 min.
RoTat 1.2 PCR was carried out in a 25 μl reaction mix-
ture containing1x Hot Star Taq Master Mix (Qiagen),
0.8 μM of forward and reverse primers and 1.0 μl of
template DNA. The cycles included activation of the hot
start Taq polymerase at 94 °C for 15 min, followed by
40 cycles of denaturation at 94 °C for 30 s, primer an-
nealing at 52 °C for 30 s, and elongation at 72 °C for
30 s. Final elongation was continued at 72 °C for 5 min.
EVAB PCR was carried out in 25 μl reaction mixtures
containing 1x Hot Star Taq Master Mix (Qiagen), 0.8 μM
of each primer and 1.0 μl of template DNA. The cycling
conditions for PCR were an initial denaturation step at 94 °
C for 15 min, followed by 30 cycles of denaturing at 94 °C
for 30 s, annealing at 60 °C for 30 s and extension at 72 °C
for 60 s. A final elongation was continued at 72 °C for
10 min. A positive (reference T. evansi DNA, 10 ng/ml)
and a negative control (sterile water) were included for
each PCR reaction. Amplified products were analysed by
electrophoresis in a 2 % agarose gel (Eurogentec, Belgium)
and UV illumination (Syngene, UK) after ethidium brom-
ide staining of the DNA (Sigma, Belgium).
Statistical analysis
Statistical analysis was performed using SPSS version 15.
Levels of agreement between diagnostic tests were indi-
cated by kappa values (k) and interpreted according to
Landis and Koch [40] and the influence on prevalence of
various factors, such as breed, gender, age and locality
was determined using chi-square test along with odds
ratios and their 95 % confidence intervals.
Results
Degree of agreement between the different diagnostic
tests
Cross tables and degree of agreement for all test combi-
nations are represented in Table 2.
Considering that molecular tests are surrogates for para-
site detection, it is clear that agreement between parasite
detection with GST and DNA detection with TBR1/2 PCR
(k = 0.03) and RoTat 1.2 PCR (k = 0.03) is slight, as it isPrimersequence Reference






Table 2 Cross-tables and degree of agreement between the different diagnostic tests. TL = immune trypanolysis, GST = Giemsa
stained thin smear, FGT = formol gel test, TL = immune trypanolysis, CATT = CATT/T. evansi, ELISA = ELISA/VSG RoTat 1.2, pos = positive,
neg = negative, CI = 95 % confidence interval, k = kappa with the following interpretation of agreement: <0 = poor, 0–0.2 = slight,
0.21-0.4 = fair, 0.41-0.6 = moderate, 0.61-0.8 = substantial, 0.81-1 = almost perfect
FGT CATT ELISA TL TBR1/2 RoTat 1.2
pos Neg pos neg pos neg pos neg pos neg pos neg
GST pos 7 0 7 0 1 6 7 0 7 0 7 0
neg 396 602 472 526 443 555 394 604 314 684 300 698
k (95 % CI) 0.02 (0–0.096) 0.02 (0–0.080) <0 0.02 (0–0.096) 0.03 (0–0.119) 0.03 (0–0.123)
FGT pos 222 181 164 239 192 211 114 289 113 290
neg 257 345 280 322 209 393 207 395 194 408
k (95 % CI) 0.12 (0.058-0.182) <0 0.13 (0.066-0.193) <0 <0
CATT pos 301 178 299 180 157 322 152 327
neg 143 383 102 424 164 362 155 371
k (95 % CI) 0.36 (0.300-0.416) 0.43 (0.378-0.490) 0.02 (0–0.079) 0.02 (0–0.086)
ELISA pos 310 134 142 302 137 307
neg 91 470 179 382 170 391
k (95 % CI) 0.54 (0.489-0.594) 0.00 (0–0.065) 0.01 (0–0.070)
TL pos 136 265 131 270
neg 185 419 176 428
k (95 % CI) 0.04 (0–0.100) 0.04 (0–0.103)
TBR1/2 pos 307 14
neg 0 684
k (95 % CI) 0.97 (0.951-0.985)
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RoTat 1.2with which agreement is poor (k < 0). On the
other hand, agreement between the two DNA detection
tests, TBR1/2 PCR and RoTat 1.2 PCR, is almost perfect
(k = 0.97). Agreement between the non-specific FGT
and the other serological tests varies from poor to slight
(k ≤ 0–0.2) while agreements between all tests that specif-
ically detect antibodies against RoTat 1.2 VSG range from
fair to moderate (k >0.21 - 0.6) (CATT/T.evansi and
ELISA/VSG RoTat 1.2: k = 0.36; CATT/T. evansi and TL:
k = 0.43; ELISA/VSG RoTat 1.2 and TL: k = 0.54). Agree-
ment between all serological tests and the molecular tests
is poor to slight (k ranging from < 0 to 0.04).
Overall prevalence
Using different tests, the overall prevalence estimates
were statistically different from each other (p < 0.0005).
Among1005 camels screened for T. evansi infection, the
overall prevalence was found to be 0.7 % (95 % CI: 0.08-
1.32) with GTS, 40.1 % (95 % CI: 37.07-43.13) with FGT,
47.7 % (95 % CI: 44.57-50.75) with CATT/T.evansi,
44.2 % (95 % CI: 41.11-47.25) with ELISA/VSG RoTat
1.2, 39.9 % (95 % CI: 36.87-42.93) with TL, 31.9 % (95 %
CI: 29.06-34.82) with TBR1/2 and 30.5 % (95 % CI:
27.70-33.40) with RoTat1.2 PCR (Table 3).Prevalence according to district
All parasitological positive cases were reported from
the Bahawalpur (Table 3). Using TL as gold standard
test for T. evansi specific antibodies, the highest sero-
prevalence was reported from Bahawalpur 48.8 % (95 %
CI: 37.1-43.1), followed by Bahawalnagar 34.3 % (95 %
CI: 37.1-43.1) and 31.7 (95 % CI: 25.0-41.03). The sero-
prevalence estimates from Bahawalpur and Rahim Yar
Khan were found to be significantly different (χ2 = 24.2,
df = 1, p = 0.0001). Molecular prevalence estimates using
both TBR1/2 PCR and RoTat 1.2 PCR were found to
be significantly lower at Bahawalpur than both Rahim
Yar Khan (χ2 = 11.34, df = 1, p = 0.001, χ2 = 4.43, d =1,
p = 0.035) and Bahawalnagar (χ2 = 23.0.7, df = 1, p = 0.000,
χ2 = 21.76, df = 1, p = 0.0005). Applying TL, and TBR1/2,
the camels at Bahawalpur are approximately two times
more likely to be infected than those in Bahawalnagar
(OR = 1.8; 95 % CI: 1.38-2.42) and Rahim Yar Khan
(OR = 1.89; 95 % CI: 1.30-2.75) respectively.
Prevalence according to gender
Six out of the seven parasitologically positives were fe-
males (Table 3). Using TL as gold standard test for anti-
bodies, females were found to have a significantly
higher prevalence than males (χ2 = 8.6, df = 1, p =
0.0034). On the contrary, a higher molecular prevalence
Table 3 Number and percentage (%) of positive samples in the different diagnostic tests. Data are arranged according to district,
breed, gender and age group. GST = Giemsa stained thin smear, FGT = formol gel test, TL = immune trypanolysis, CATT = CATT/T.
evansi, ELISA = ELISA/VSG RoTat 1.2, pos = positive, neg = negative
GST FGT CATT ELISA TL TBR1/2 RoTat1.2
Total pos (%) pos (%) pos (%) Pos (%) pos (%) pos (%) pos (%)
District Bahawalpur 420 7 (1.1) 259 (61.7) 224 (53.3) 210 (50.0) 205 (48.8) 95 (22.6) 94 (22.4)
Bahawalnagar 399 0 (0.0) 144 (36.1) 202 (50.6) 156 (39.1) 13 7(34.3) 155(38.9) 152 (38.1)
Rahim Yar Khan 186 0 (0.0) 0 (0.0) 53 (28.5) 78 (41.9) 59 (31.7) 68 (36.6) 58 (31.2)
Breed Brella 420 3 (0.7) 245 (58.3) 201 (47.9) 171 (40.7) 166 (39.5) 119 (28.30) 118 (28.1)
Mareecha 585 4 (0.7) 158 (27.0) 307 (52.5) 273 (46.7) 235 (40.2) 199 (34.0) 186 (31.8)
Gender Male 440 1 (0.2) 105 (23.9) 196 (44.5) 200 (45.5) 153 (34.8) 164 (37.3) 155 (35.2)
Female 565 6 (1.1) 298 (52.7) 283 (50.1) 244 (43.2) 248 (43.9) 154 (27.3) 149 (26.4)
Age Adult 659 7 (1.1) 302 (45.8) 328 (49.8) 295 (44.8) 267 (40.5) 214 (32.5) 208 (31.6)
Young 187 0 (0.0) 64 (34.0) 90 (48.1) 82 (43.9) 70 (37.4) 53 (28.3) 49 (26.2)
Calf 159 0 (0.0) 37 (23.3) 61 (36.4) 67 (42.1) 64 (40.1) 51 (32.1) 47 (29.6)
Total 1005 7 (0.7) 403 (40.1) 479 (47.7) 444 (44.2) 401 (39.9) 321 (31.9) 307 (30.5)
Tehseen et al. Parasites & Vectors  (2015) 8:415 Page 7 of 11was observed in males than in females (χ2 = 9.9, df = 1,
p = 0.002). Molecular estimates by both TBR1/2 PCR
and RoTat1.2 PCR, show that males were 1.5 times
more likely to be infected than females (OR = 1.57;
95 % CI: 1.2-2.1, 1.56; 95 % CI: 1.15-1.97).Prevalence according to breed
No significant differences were found between preva-
lence in breeds with any diagnostic test other than FGT
(χ2 = 99.9, df = 1, p = 0.000) (Table 3).Prevalence according to age group
All GST positives were adults resulting in a significant
difference in prevalence estimates between adults on
the one hand and young and calves on the other handFig. 2 Mean PCV with standard deviation according to status in the differe
test, TL = immune trypanolysis, CATT = CATT/T. evansi, ELISA = ELISA/VSG Ro
between positives and negatives (p < 0.05)(χ2 = 9.9, df = 1, p = 0.002) (Table 3). None of the other
applied diagnostic tests showed a significantly different
prevalence between these two groups.Packed cell volume
PCV in function of status in the different diagnostic
tests is represented in Fig. 2. Mean PCVs were non sig-
nificantly and significantly higher for both parasitologic-
ally positive and FGT positive animals respectively (p <
0.05). On the other hand, animals that were positive in
all the other serological tests and the molecular tests
had a significantly lower average PCV than negative ani-
mals. Significant differences in PCV were also observed
between PCR positive and negative animals in all the
groups (age, breed, gender, and districts).nt diagnostic tests. GST = Giemsa stained thin smear, FGT = formol gel
Tat 1.2, pos = positive, neg = negative. * = significant difference
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In this study, we aimed at investigating the prevalence of
camel trypanosomosis in the Cholistan Desert, assessed
by different diagnostic techniques including parasite de-
tection, serology and molecular diagnostics.
Parasitological prevalence, assessed by Giemsa stained
thin smear was much lower (0.07 %) than molecular
prevalence (30.5 - 31.9 %), which is not unexpected given
the high sensitivities of molecular tests. More animals
could have been confirmed with trypanosomes if parasito-
logical examination was performed with the haematocrit
centrifugation technique (HCT) or by mouse inoculation
but for this study, we had no access to both techniques in
the field. If we consider the molecular tests as 100 % spe-
cific, the very high ratio of PCR- over GST-positives can
be explained by low parasitaemia levels typical for the
chronic stage of infection [41]. With about 1/3 of the
camels actually infected, T. evansi infection is highly
prevalent in the study population and definitely higher
than what was observed in other studies in camel and in
buffaloes in Pakistan [26, 27, 41]. This high prevalence
rate is also reflected in the serological results where about
40 % of the study population showed detectable antibodies
against T. evansi RoTat 1.2 in the immune trypanolysis,
the reference antibody test which is considered 100 % spe-
cific [15]. Since antibodies can remain in the circulation
for several months after cure and since only 17 % of all an-
imals had no history of anti-trypanosome treatment (data
not shown), it is not surprising that serological prevalence
is higher than molecular and parasitological prevalence.
The high proportion of positive specimens recorded with
the different tests proves that surra is highly prevalent in
the Cholistan Desert, similar to other regions, e.g. in
Kenya [12, 33]. Since this is the first time that CATT/T.
evansi and ELISA/VSG RoTat 1.2 are used in Pakistan, we
cannot compare our data with those from other sero-
prevalence studies on surra in Pakistan except the study of
Nadeem et al. who found 6 % of 200 horses from Gujran-
wala district positive in an immunofluorescence test [42].
One other study by Aslam et al. reported 21.6 % preva-
lence in 120 equine samples using antibody ELISA kit
(FAO/IAEA, Vienna, Austria) [43].
Although the agreement between GST and the other
diagnostic tests was poor, all parasitologically positive ani-
mals were also positive in FGT, TBR1/2 PCR and the dif-
ferent RoTat 1.2-based tests except for one animal that
was negative in ELISA/VSG RoTat 1.2. This finding is
consistent with the earlier studies of Verloo et al. where it
was shown that the majority of T. evansi type A strains
from all over the world express the RoTat 1.2 VSG shortly
after infection [44]. Only one study described the exist-
ence of T. evansi type A strains from Kenya that doesn't
contain the RoTat 1.2 VSG gene [5]. The fact that one
parasitologically confirmed animal was negative in ELISA/VSG RoTat 1.2 but positive in TL, can be explained by the
use of filter paper eluate instead of plasma, thus reducing
the sensitivity of ELISA and/or by the higher analytical
sensitivity of TL [35].
Except for the fact that all parasitologically confirmed
animals were positive in the FGT, this serological test
showed poor to slight accordance with any other diagnos-
tic test for surra applied in the present study. The high
numbers of discordant specimens confirms the poor sen-
sitivity and poor specificity of the FGT compared to the
other diagnostic tests reported in many other studies, in-
cluding on visceral leishmaniasis in human [45]. The ap-
parently poor specificity of the FGT is explained by the
fact that it detects, in a non-specific way, high concentra-
tions of plasma immunoglobulins that can be due to any
acute or chronic infection causing hypergammaglobuline-
mia. The fair to moderate agreement among the other,
VSG specific, serological tests is expected from what has
been observed in comparative studies on experimentally
and in naturally infected animals [15, 18, 35, 44]. Among
the antibody detection tests for surra as well as for human
African trypanosomosis, the TL is considered to be highly,
if not 100 % specific [3, 35, 46]. Thus, with TL as gold
standard for antibody detection, false positives in CATT/
T. evansi and ELISA/VSG RoTat 1.2 are explained by the
exposure of cross-reacting epitopes in the CATT and
ELISA antigens while false negatives may be the result of
the higher analytical sensitivity of TL [35].
Concordance of CATT/T. evansi, ELISA/VSG RoTat 1.2
and TL with the molecular tests is poor. False positives
can be due to specific antibodies that remain present after
treatment as explained above. On the other hand, the high
number of false negatives in serology compared to the
molecular tests is puzzling and cannot be explained by the
use of filter paper eluates for ELISA/VSG RoTat 1.2 and
TL since a similar number of false negatives is also ob-
served in CATT/T. evansi that was performed on plasma.
The almost perfect concordance between the two molecu-
lar tests targeting totally different sequences in the tryp-
anosome genome strongly indicates the presence of
trypanosome DNA in these serologically negative speci-
mens and we didn't find any positive reaction in the T.
evansi type B specific EVAB PCR (data not shown). In
addition, from the negative controls included during the
DNA extraction and in the PCR, we couldn't find evidence
of cross-contamination. Therefore, the serologically false
negatives must remain unexplained unless we consider
the molecular tests not as fully specific or we accept that
between 15 % and 18 % of all studied animals carried re-
cent infections and were sampled prior to the appearance
of RoTat 1.2 specific antibodies.
In this study, a high prevalence of surra has been ob-
served in all three districts of Cholistan Desert using
different techniques. In addition to finding all GTS
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also reported from the same district. On the contrary,
the molecular prevalence is reported to be highest at
Bahawalnagar thereby suggesting that Cholistan is a
high risk area of surra affected from both past and re-
cent active infection. This can be explained by eco-
logical similarity and presence of infrastructure in
terms of connectivity between different districts and
equally distributed heavy spells of rain as experienced
lately. This is directly related to vector abundance and
a higher dissemination rate of the disease [8].
The fact that there was a significantly higher seropreva-
lence in females and a higher molecular prevalence
amongst males shows that both sexes are highly suscep-
tible to disease although males were having a more active
infection at time of sampling. Moreover, six of the seven
parasitologically positive animals were females. The higher
prevalence in adult females might be due to pregnancy
and lactation, which may reduce resistance in female
camels and render them more susceptible to infection
[25]. On the other hand, increased infection in males can
be explained by the fact that male camels may be in stress
due to fatigue owing to physical work, travelling in terms
of searching for food and water, and hence more exposure
to vectors. Bogale et al. reported a greater prevalence in
males than females while studies by Ngaira et al. reported
no difference in prevalence [47, 48]. Mareecha camels
were reported to have a greater prevalence than Brella al-
though the difference was not significant.
In the current studies, higher prevalence estimates in
adult population than non-adult camels is in agreement
with the studies of Jacquiet et al. and Diall et al. [49, 50].
This can be attributed to various factors like overesti-
mation of disease owing to, persistence of antibodies
following treatment, chronic nature of infection and
intermittent parasitaemia, stress, poor management,
draught, poor silage and preference by vectors because
of larger surface area. Non-adults are often reported to
be less affected group as they may go unnoticed because
of high mortality owing to severity of disease, prefer-
ence by the pastoralists to keep these animals in the
same residing area and restricted movement to distant
vector abundant areas [51–53]. In the non-adult popu-
lation, TL and both PCRs gave higher prevalence in
calves than young camels unlike CATT and FGT. Hence
it can be concluded that although young camels are
more susceptibility to surra after waning of maternally
transferred immunity, a higher prevalence in calves can
be attributed to the fact that both the groups were
reared in the same area and were exposed to the same
risk [54].
Anemia is considered as one of the characteristic find-
ings in animals suffering from surra [55]. Therefore; the
finding of higher PCV values in parasitologically positiveanimals is unexpected but may be attributed to the fact
that GST detected only a small fraction of actually in-
fected animals rendering the difference in PCV between
parasitologically positive and negative animals non-
significant. The significantly higher PCV in FGT positive
animals is also unexpected but may be explained by our
data proving that FGT is not accurately detecting active
infection with T. evansi, which is further illustrated by
the poor agreement of FGT with any other diagnostic
test used in this study. On the other hand, animals that
were positive in the serological tests had a significantly
lower PCV. This lower PCV is even more obvious in the
animals with a positive result in the molecular tests, thus
strengthening the suggestion that molecular tests are
more accurate in detecting active infection than sero-
logical tests since the latter may remain positive after
cure. In various studies on surra in camels, PCV cut-off
values have been proposed for diagnostic purposes such
as 23 %, 20 % and 18 % [47, 50, 56]. In principle, our
data would also allow to propose a cut-off value (e.g.
23.5 %) but it is questionable that a difference of 2 % be-
tween infected and non-infected animals is sufficient to
accurately diagnose an infection. This does not exclude
that the combination of a low PCV and positivity in a
molecular and, especially, in a serological test may have
a diagnostic value.
Our study has some limitations. First of all, we were
not able to isolate T. evansi strains. Some mice inocu-
lated with the blood of parasitologically confirmed
camels became parasitaemic within a few days but died
before a cryostabilate could be prepared. Secondly, no
rigorous and complete clinical data collection was per-
formed. We can only report that 3 out of the 7 para-
sitologically confirmed animals showed signs of acute
infection with fever, anorexia, generalised oedema and
eventually died, whereas the 4 other showed signs of
chronic infection such as progressive loss of body
weight, intermittent high fever, muscular atrophy, pale
mucous membrane, blindness, characteristic sweet
odour due to urinary ketones and faulty gait. These
chronic cases were successfully treated with Trypami-
dium (0.5 mg/kg).
Conclusion
According to our knowledge, this is the first report on T.
evansi infection in camels in Pakistan making use of a
combination of parasitological, serological and molecular
tests, including those that are recommended by OIE. This
study indicates that surra caused by T. evansi type A is cir-
culating in dromedary camels of all age groups, breeds
and gender in all districts of the Cholistan Desert. Since
no test is 100 % sensitive and 100 % specific and not all
tests can be applied in the field, the choice of which test
to deploy during surveys and in routine diagnostic
Tehseen et al. Parasites & Vectors  (2015) 8:415 Page 10 of 11practice will depend on the test characteristics. For rou-
tine diagnostic practice, the CATT/T. evansi is appropri-
ate but decision to treat will not only depend on CATT
positivity but also on the clinical aspect and history of try-
panocidal treatment. In case parasitological examination is
desired, GST has no value and should be replaced by con-
centration techniques like MHCT or mAECT. For large
scale surveys that can rely on proper laboratory facilities,
ELISA/VSG RoTat 1.2 is more appropriate and cheaper
than PCR and can be performed on filter paper eluates.
Given the high prevalences observed, we recommend to
establish measures to decrease disease incidence by treat-
ment of infected animals and by controlling the vector.
We further recommend to investigate the prevalence of T.
evansi in other domestic animals, like sheep and goats, liv-
ing in the same environment. Finally, we recommend to
isolate the T. evansi strains circulating in the Cholistan
Desert for extended studies on their pathogenicity, genetic
relationship with strains from other geographical origin
and drug sensitivity.
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